Insider · CIK 0001935353
Jeffrey Wang
Files at SONM (DNA X, Inc.). First filing Apr 25, 2025, latest Apr 25, 2025.
Jeffrey Wang files SEC Form 4 as director at SONM (DNA X, Inc.). Since Apr 25, 2025, Jeffrey Wang has reported 0 open-market buys worth $0 and 1 open-market sell worth $6,493, the latest filed on Apr 25, 2025.
A track record needs three past buys with six months of prices behind them; Jeffrey Wang has 0, so none is measured yet.
The newest scored trade: sold $6,493 of SONM on Apr 23, 2025, filed Apr 25, 2025, scored 35 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SONM: DNA X, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | DNA X, Inc. | $6,493 4,478 shares | -17% | +10% from low-62% from high |
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 23, 2025 | SONM DNA X, Inc. | SOpen-market sale Common Stock | -4,478 | $1.45 | $6,493 | 21,301 | Apr 25, 2025 |
Questions about Jeffrey Wang
Answered from the filings on this page, as of the latest one.
Is Jeffrey Wang buying or selling?
Not in the last 12 months. Jeffrey Wang's latest open-market trade on SEC Form 4 was sold $6,493 of SONM on Apr 23, 2025.
How did Jeffrey Wang's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jeffrey Wang has 0.
Where does Jeffrey Wang file Form 4?
Jeffrey Wang has filed Form 4 at SONM (DNA X, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.